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In this study we evaluate macroporous scaffolds made of alginate-chitosan polyelectrolyte complexes (PEC) as 
tools to optimire the results of soft tissues œll therapy. Cell therapy using mesenchymal stem cells (MSC) bas 
become attractive for tissue repair and regeneration in a number of acute and chronic injuries. Unfortunately 
their low retention and/or survival after injection limit their beneficial effects. A biomaterial-assisted im­
plantation, providing œlls a thr�mensional (3D) microenvironment is a promising strategy. To this purpose, 
we designed a family of PEC scaffolds, and studied if they could meet the requirement of such application. Xray 
tomography showed that ail PEC scaffolds present an interconnected macroporosity, and both rheology and 
tensile measurements reveal optimized mechanical properties (higher storage moduli and Young moduli) 
compared to alginate referenœ scaffolds. In vitro assays demonstrated their ability to allow MSC retention 
(higher than 90%) , long-term viability and RiF2 secretion. Then, we used a skeletal muscle implantation mode! 
to assess the biological response to scaffolds graft, and showed that they support in vivo vascular formation 
within the implant-derived tissue. The combination of alginate/chitosan PEC scaffolds architecture and angio­
genic potential make them appear as interesting tools to optimize MSC therapy results in soft tissues. 
1. Introduction
In recent years, cell therapy using Bone Marrow Mesenchymal Stem 
Cells (BM MSC) has become an attractive tool for tissue repair and re 
generation in a number of acute and chronic injuries. Ahhough the first 
studies in the field suggested that the beneficial effects of administered 
BM MSC might be related to their terminal differentiation in the host 
œll type, this mechanism of action is controversial. In contrast, it is now 
well established that BM MSC promote repair of injured tissues through 
the secretion of a variety of paracrine growth (basic fibroblast growth 
factor [b FGF), insulin like growth factor 1 [IGFl), hepatocyte growth 
factor [HGF)) immunomodulatory (interleukine 10 [IL 10)) and an 
giogenic (vascular endothelial growth factor a [VEGF a)) factors 
(Shologu et al., 2018). They act as mini pumps secreting locally factors 
whose properties are particularly attractive for the remission of is 
chemic injury. In particular, we (Mias et al., 2009) and others (Gnecchi 
et al., 2006) supported the importance of FGF produced by BM MSC in 
promoting tissue repair after renal (Mias et al., 2009) and cardiac 
(Gnecchi et al., 2006) ischemia. Furthermore, we have already shown 
that MSCs encapsulated in alginate scaffolds maintain their capacity to 
produœ FGF2 (Trouche et al., 2010) and VEGF, FGF2, HGF, EGF, IGF 1 
and G CSF after 28 days of encapsulation (Ceccaldi et al., 2012; 
Ceccaldi et al., 2017), and retain their initial phenotype and ability to 
differentiate later under a differentiating medium (Trouche et al., 2010; 
Ceccaldi et al., 2012). 
The benefits of BM MSC therapy has been demonstrated in the 
management of ischemic damage of several tissues including heart 
(Hare et al., 2009; Williams and Hare, 2011; Karantalis et al., 2014 and 
Bartunek et al., 2013; Mias et al., 2009; Amsalem et al., 2007; Feygin 
et al., 2007; Perin et al., 2008), kidney (Mias et al., 2008; Qi and Wu, 
2013; Reis et al., 2012; Toge! and Westenfelder, 2012), Jung (Souidi 
et al., 2013), liver (Pan et al., 2012; Chen et al., 2012; Wang et al., 
2014), vasculature (Poitevin et al., 2014) and brain (Li et al., 2005; 
Chopp et al., 2009). In these studies, BM MSC have been delivered by 
systemic intravenous infusion or injected into the targeted organ. 
However, data from preclinical and clinical trials suggest that their 
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properties of the obtained PEC (in the range of several MPa). The use of
PEC formation has more rarely been reported for soft tissue applica
tions. In a previous study, we have shown that a combination of process
and formulation parameters can lead to a family of alginate chitosan
PEC scaffolds suitable for cardiac applications (Ceccaldi et al., 2014). In
this study, we explore if these scaffolds could match the specifications
for soft tissue treatment by MSC. We hypothesized that biomaterial
design can lead to a construct whose architecture could permit good
cell retention and viability combined with angiogenic potential. To this
purpose, we designed alginate/chitosan PEC scaffolds with controlled
porosity and mechanical properties and demonstrated their ability to
allow MSC retention, long term viability and FGF2 secretion in vitro.
Next, as a proof of principle, we used a skeletal muscle implantation
model to assess the biologic effect of the obtained constructs to support
in vivo vascular formation within the implant derived tissue.
2. Materials and Methods
2.1. Materials
Sodium alginate (molecular weight 80,000 120,000; ratio M/
G=1.56), chitosan (molecular weight 190,000 310,000; 84.6% dea
cetylated), HEPES sodium salt, Dulbecco's Phosphate Buffered Saline
(DPBS) without calcium chloride and magnesium chloride, as well as
antibiotics penicillin streptomycin were purchased form Sigma Aldrich,
France. Calcium chloride dihydrate (CaCl₂·2H₂O) and sodium chloride
(NaCl) were purchased from VWR. Fetal Medium for cell culture was
prepared by supplementing the MEMα with 10% fetal bovine serum
and 1% penicillin streptomycin.
2.2. Preparation of Alginate/Chitosan Macroporous 3D Scaffolds
Three dimensional alginate/chitosan PEC scaffolds (containing al
ginate/chitosan weight ratio of 60/40, 50/50 and 40/60) were pre
pared by a freeze drying technique following a method reported pre
viously (Ceccaldi et al., 2014). Briefly, 100 μl of polyelectrolyte
solutions or 200 μl of single polymer solution (pure alginate (ratio 100/
0) or of pure chitosan (ratio 0/100) 1.5% w/w,used as controls) were
placed in a 96 well plate, frozen overnight at −20 °C and lyophilized.
Constructs were cross linked in an isoosmotic buffer (pH 7.4) con
taining 150Mm NaCl, 0.1 M CaCl₂·2H₂O, and 12.5mM HEPES during
1 h. Pure chitosan scaffolds were cross linked with NaOH 1M. All
scaffolds were washed 2 times during 1 h in a HEPES buffer (pH 7.4),
and lyophilized again. The final scaffolds dimensions, used in all ex
periments, were 5mm diameter × 2.5mm thickness.
2.3. Physico chemical Characterization
2.3.1. Computed X ray Micro tomography (Micro CT)
The micro CT study of samples was carried out on Phoenix Nanotom
180 (GE Sensing, Germany) using the following parameters: 30 kV
voltage, 160 microA current, no filter material, 0.25° rotation step, 5
frames as frame averaging, 1440 tomographic projections over a 360°
scan angle, 1 s exposure time. A binning 2×2 was applied for the slices
reconstruction and the resulting voxel size was 11.5 μm3. Three di
mensional virtual models of scaffolds were obtained using VGStudio
MAX 2.1. A region of interest (ROI) was drawn within the reconstructed
volume and a threshold was defined to identify the polymeric phase.
Then, a morphometric analysis of the ROI was performed to obtain the
total porosity and void interconnectivity. Scaffolds' morphologies were
analyzed on the basis of 2D X ray tomographic slices using ImageJ
(NIH, USA). Calculations were done on a ROI defined on the surface and
in the cross section of each scaffold. Feret's diameters were obtained
and pore densities were calculated as the total void number/ROI area
(n=10 slices per scaffold). Voids on edges were excluded.
intravascular or intraparenchymal injection results into a low rate of 
retention and/or survival. Intravenous perfusion is hampered by low 
retention rates within 24 h of delivery, typically < 10%, and a long 
term survival and engraftment < 1% (Mäkelä et al., 2015; Malliaras 
and Marbán, 2011; Cheng et al., 2013). Direct intraparenchymal in 
jections results in better retention of cells, but leads to poor survival 
rates, generally < 1% (Toma et al., 2002; Feygin et al., 2007; Morigi 
et al., 2008; Cheng et al., 2013; Wang et al., 2014).
To address the need for increased retention and better viability of 
transplanted cells, a promising strategy is to associate MSCs with a 
biocompatible material that protects and concentrates them on the 
damaged area (Noronha et al., 2019). For tissue engineering applica 
tions, macroporous scaffolds are of particular interest since they allow 
improved cell invasion and rapid exchange of nutrients, oxygen and 
metabolic wastes, while providing the scaffold seeded cells a three di 
mensional (3D) microenvironment. As a consequence scaffold's design 
is decisive to optimize cell therapy results. Key requirements include 
control of scaffold's porosity, mechanical properties, and biocompat 
ibility. It has been established that pore size and distribution affect the 
biological performance of the construct by influencing cell morpho 
genesis (Zmora et al., 2002), cell behaviors and host cell colonization 
(Zeltinger et al., 2001; Salem et al., 2002). Therefore, the ideal scaffold 
should present an interconnected porosity with pore sizes compatible 
with 3D cell culture. In addition, the ideal scaffold should present 
mechanical properties that not only suit the specific application (ac 
cording to the mechanical characteristics of the targeted organ) but also 
allow surgical manipulation during grafting.
Natural polymers seem to be particularly adapted for the elabora 
tion of cell carrier systems due to both their structural properties and 
high biocompatibility. Alginates are among the most commonly used 
biopolymers in regenerative medicine due to their structural simila 
rities with the extracellular matrix, their gelling properties under con 
ditions compatible with biological activities (37 °C, pH 7.4 …) and their 
low cytotoxicity. They are naturally occurring anionic linear (un 
branched) polysaccharides, which can be extracted from kelp, brown 
seaweed and some bacteria. In terms of chemical structure, alginates 
are salts of alginic acid consisting of 1,4 linked β D mannuronic (M) 
and α L guluronic (G) residues organized in regions of sequential G 
units (G blocks), sequential M units (M blocks) and G and M units 
atactically organized. Their sol gel transition properties are based on 
the formation of a stiff “egg box” structure due to divalent cations se 
lective binding to the G blocks of two adjacent polymeric chains. A 
number of studies have demonstrated the benefits of alginate 3D scaf 
folds seeded with various cell types for the regeneration of heart (Zieber 
et al., 2014; Dvir et al., 2009; Leor et al., 2000), liver (Dvir Ginzberg 
et al., 2008) and kidney (Kim et al., 2003). Although this therapeutic 
approach seems promising, the use of alginate macroporous scaffolds as 
implantable devices is challenged by drawbacks such as fragility 
(Ceccaldi et al., 2012) and lack of specific signals for cell attachment 
(Shachar et al., 2011). Strategies to improve alginate properties may 
entail chemical modifications leading to potentially toxic reactive in 
termediates. One alternative to chemical modification is to associate 
alginate with a cationic polymer like chitosan, to form polyelectrolyte 
complexes of opposite charge (PEC) with improved properties. Chitosan 
is a cationic copolymer of b(1 4) 2 acetamido 2 deoxy b D gucopyr 
anose and 2 amino 2 deoxy b D glucopyranose, obtained by deacetyla 
tion of naturally occurring chitin. Chitosan is a biocompatible and 
biodegradable polymer whose applications in the tissue engineering 
field include regeneration of bone and articular cartilage (Malafaya and 
Reis, 2009; Ahmed and Hincke, 2014), heart (Hussain et al., 2013; 
Wang et al., 2010), kidney (Gao et al., 2012), skin (Azad et al., 2004), 
and nervous tissue (Gnavi et al., 2013; Zahir et al., 2008).
Use of alginate/chitosan porous scaffolds has been described mainly 
in the field of bone and cartilage tissue engineering (Florczyk et al., 
2013; Li et al., 2015; Li and Zhang, 2005; Qi et al., 2011; Li et al., 2008; 
Shao and Hunter, 2007; Li et al., 2005) due to the increased mechanical
in vitro culture constructs were washed two times with a mix of MEMα
and physiological serum (ratio 1/1). Staining solution containing 2 μM
ethidium homodimer 3 (necrotic marker measuring nucleus membrane
integrity) and 1 μM calcein AM (viability marker measuring the in
tracellular esterase activity) was prepared in a mix of MEMα and
physiological serum 1/1 to stain dead cells in red and live cells in green.
Scaffolds were incubated in the staining solution during 30min in the
dark at room temperature, then washed twice with DPBS and im
mediately observed under a confocal microscope Zeiss LSM510 using a
10× objective. The samples were excited with a 488 nm Argon laser
and with a 543 nm helium neon laser. The emitted fluorescence was
collected using two separate photomultiplier tubes with a BP
500 560 nm filter for calcein detection and a LP 620 nm filter for
ethidium homodimer 3 detection. The 3D reconstructions were gener
ated using Image J (NIH, USA) from microscopic images where the
green and red channel were merged.
2.4.4. Evaluation of Cell Retention After Seeding Within 3D Scaffolds
The efficiency of cell retention after seeding within scaffolds was
evaluated by measuring the total lactate dehydrogenase (LDH) activity
of cell seeded scaffolds (3D) and of cells left at the bottom of the well
(residual) using the Pierce LDH Cytotoxicity Assay Kit (Thermo
Scientific). Sixteen hours after seeding, the scaffolds were immersed
into a lysis solution and then the total LDH activity was measured ac
cording to the manufacturer's instructions. Absorbance was read at
450 nm (specific signal) and 620 nm (background signal) using a plate
reading spectrophotometer (Infinite® 200Pro, Tecan Group). After
subtraction of the background signal, cell retention efficiency was cal
culated as follows:
= − + ×Retention efficiency (%) 1 (LDH /(LDH LDH )) 100.residual residual 3D
In addition, a standard curve was established using scaffolds seeded
with a known number of MSCs (culture medium and acellular scaffolds
served as blank). All measurements were performed in triplicates.
2.4.5. Cell Proliferation in Scaffolds
MSC proliferation in different 3D scaffolds was assessed by mea
suring the double stranded genomic DNA content. On 0, 1, 3, 7 and
14 days of culture, the scaffolds were taken out of the culture plate
wells, placed in Eppendorf tubes containing one 5 mm stainless steel
bead each, and grinded using a mixer mill (Retsch). After that, total
DNA was extracted using the GenElute Mammalian Genomic DNA
Miniprep Kit (Sigma Aldrich) as specified by the manufacturer.
Finally, double stranded DNA content was quantified using the
PicoGreen assay (Life Technologies). One hundred microliters of the
eluate, containing pure genomic DNA, were transferred to a flat black
96 well plate and the fluorescence was measured at an excitation wa
velength of 485 nm and an emission wavelength of 535 nm using a plate
reader (Infinite® 200Pro, Tecan Group).
In parallel, two standard curves were established: one curve using
purified double strand DNA (DNA diluting buffer was used as blank)
and another curve using DNA extracted from scaffolds seeded with a
known number of MSCs (acellular scaffolds were used as blank). All
measurements were performed in triplicates.
2.4.6. Scanning Electron Microscopy (SEM)
40/60 PEC scaffolds were seeded with MSCs and cultured in vitro in
cell culture medium according to the protocol previously described.
After 3 days of culture, the samples were fixed in 3% glutaraldehyde in
0.1 M cacodylate buffer at 4 °C. The samples were subsequently coated
under vacuum with platinum alloy, then immediately flash carbon
coated under vacuum. The surfaces of the cell seeded scaffolds were
examined in an ESEM Quanta 250 FEG FEI scanning electron micro
scope at an accelerating voltage of 5 kV and a magnification of 7000
times.
2.3.2. Swelling
The swelling behaviors of the scaffolds were studied at room tem 
perature by measuring their weights in a dry (Wdry) and in a wet (Wwet) 
state using an electronic balance. A dry scaffold was placed in a mesh 
basket and then immersed in an excess of culture medium. At regular 
time intervals the basket containing the wet scaffold was taken out of 
the medium, drained on an absorbent paper and weighed. The swelling 
ratio was calculated using the following formula:
Swelling ratio (Wwet= − Wdry)/Wdry
2.3.3. Rheological Characterization
Rheological measurements were carried out using a stress con 
trolled rheometer (Rheostress RS75, HAAKE, Germany) with a parallel 
plate geometry. Test samples matching the diameter of the plate 
(20 mm) were prepared. After complete rehydration in culture medium, 
the specimens were carefully laid on absorbent paper to remove excess 
liquid before lowering the rheometer top plate. Stress sweeps at a 
constant frequency of 1 Hz were first performed to obtain the linear 
viscoelastic region for collecting subsequent data. Then, frequency 
sweeps were performed in the linear viscoelastic regime to determine 
the storage modulus (G′) and the loss modulus (G″).
2.3.4. Tensile Testing
The scaffolds' tensile properties were evaluated through a uniaxial 
tensile test performed using a TA XT2 Texture Analyzer (Stable 
Microsystems, UK) with tensile grips. Specimens were cut as a self de 
signed dumbbell shape (100 mm total length, 60 mm gage 
length,8.7 mm gage section), then completely rehydrated in culture 
medium at room temperature. Excess liquid was removed on tissue 
paper and the shoulders were fixed between the tensile grips. The 
specimens were stretched at a constant speed of 2 mm/s and stress 
strain curves were recorded until rupture. Tensile strength at 30% of 
elongation were calculated.
2.4. In Vitro Assays
2.4.1. Isolation and Culture of Rat Bone Marrow MSCs
Mesenchymal stromal cells were obtained from the femurs of Lewis 
male rats (Harlan, France) weighing 180 200 g as previously described 
(Ceccaldi et al., 2014; Mias et al., 2009). Briefly, anesthesia was per 
formed by intraperitoneal injection of pentobarbital (0.1 ml/100 g) 
before animals were euthanized. Bone marrow was flushed from rat's 
femur with MEMα supplemented with 10% fetal bovine serum and 1%
penicillin/streptomycin, and centrifuged (300 ×g, 5 min). Then cells 
were plated in culture flasks (10,000 cells/cm2). After 3 days, non ad 
herent cells were removed by changing the culture medium, and MSCs 
were recovered by their capacity to adhere to plastic culture dishes. 
MSCs are qualified with the expression of surface markers such as 
CD90/Thy1, CD29//Integrin alpha 9 beta 1, CD106/VCAM 1 and their 
capacity to differentiate into adipocytes, chondrocytes, and osteocytes 
in culture. MSCs were then routinely cultured and were used for the 
experiments between the third and the sixth passage.
2.4.2. MSCs Seeding on Scaffolds
Each scaffold was placed in the well of a 96 well polystyrene plate 
and seeded by adding drop wise 10 μl of cell suspension containing 
100,000 MSCs (for in vitro experiments) or 500,000 MSCs (in vivo 
study) on the top of the scaffold. The plate was centrifuged 1 min at 
400 ×g, and then 290 μl of culture medium was added. The constructs 
were cultured in a 5% CO2 incubator at 37 °C. For in vitro culture, the 
medium was changed every 2 3 days.
2.4.3. Live/Dead Assay and Confocal Microscopy
Live/Dead assays were performed using the Viability/Cytotoxicity 
Assay kit (FluoProbes®, Interchim, France). After 1, 3, 7 and 15 days of
Gene GAPDH (rat): Forward primer sequence: 5′ AGGTCGGTGTGA
ACGGATTTG 3′; Reverse primer sequence: 5′ TGTAGACCATGTAG
TTGAGGTCA 3′.
Gene FGF2 (rat): Forward primer sequence: 5′ GTGTGTGCGAACC
GGTACCT 3′; Reverse primer sequence: 5′ TATTGGACTCCAGGCG
TTCAA 3′.
2.4.8. Western Blot Analysis of Protein Expression
Protein extracts form MSCs cultured in 2D were obtained by cell
lysis in a lysis buffer composed of DPBS 1×, 1% NP40 (IGEPAL®),
12 mM sodium deoxycholate, 0.1% SDS, and supplemented with a
protease inhibitor. After centrifugation (10min, 12,000×g, 4 °C) the
supernatant and the pellet are separated. The pellet is suspended in a
Tris SDS lysis buffer (pH 6.8) composed of 0.08M Trizma® base (Sigma
Aldrich), 5% SDS and 10% glycerol. Protein extracts from MSCs cul
tured in 3D scaffolds were obtained after a homogenization in a mixer.
2.5. In Vivo Assays
2.5.1. 3D scaffolds implantation
Animal experimentations were conducted in accordance with the
European Communities Council Directive (2010/63/UE) for experi
mental animal care and were approved by local animal care and use
committees C2EA 122 (Comités D'éthique En Expérimentation
Animale). Rats were housed in an air conditioned room (SPF status)
with 12 h light and dark cycles in a controlled environment at a tem
perature of 22 ± 2 °C and a relative humidity of 45%. The animals
occupied ventilated cages (3 animals / cage) with free access to food
and water ad libitum. The bedding material is made of poplar litter and
the environment is enriched. Furthermore, the animals were observed
daily to assess the clinical state and behavior for the welfare related
assessments. Concerning, the experimentations, a randomization has
been done to elicit each group.
Animals were under general anesthesia (3% isoflurane) and me
chanical ventilation. 3D PEC scaffolds were implanted in adult female
Lewis rats (200 220 g). After the skin was prepped and sterilized with
ethanol, a small incision (about 1.3 cm) was made on the chest. The
Pectoralis major muscle was exposed and a small muscle pouch was
formed between two sets of muscle fibers using surgical scissors.
Animals were randomly divided into 2 groups. The ‘Patch’ group
(n=8) received a 40/60 PEC scaffold. Sham operated animals (n=5)
were subjected to the same surgical procedure without scaffold im
plantation. Finally, the muscle pouch was closed by a stich. The im
planted scaffolds had been hydrated for at least 12 h in MEMα under
sterile conditions and their final dimensions were 5mm diameter x
2.5 mm thickness. The surgical procedure was realized under a Zeiss
OPM1 FC microscope.
2.5.2. C reactive Protein Quantification
Measurements of C reactive protein (CRP) concentrations as an
acute phase reactant were performed on blood collected by retro or
bital bleeding on anesthetized rats from the two different experimental
groups described above using heparinized tubes. Blood samples were
centrifuged 15min at 400×g and then the plasma was collected. CRP
concentrations in plasma were evaluated using the xMAP technology
(Luminex 100™ system, Luminexcorp) with the ProcartaPlex Rat CRP
kit (eBioscience).
2.5.3. Histology
Histological analyses were performed on muscle specimens fixed in
paraformaldehyde (4% solution in DPBS, pH 7.4) and embedded in
paraffin.
For basic histomorphological evaluation, paraffin sections (4 μm
thick) were stained with hematoxylin and eosin according to standard
protocols and slides were scanned using NanoZoomer Digital
Pathology.
For immunofluorescence analyses, paraffin sections were dewaxed,
rehydrated and incubated in a Tris EDTA antigen retrieval solution
(10mM Trizma® base, 1 mM EDTA, 0.05% Tween20, pH 9) at 121 °C for
3min. After a permeabilization step (0.5% Triton 100×), nonspecific
antigen sites were saturated for 30min with a DPBS solution containing
2% of goat serum and 1% of bovine serum albumin. Sections were
stained overnight with a mouse monoclonal anti α SMA (clone 1A4,
Sigma Aldrich, 1:1000, 4 °C) and a polyclonal rabbit anti VWF (A0082,
Dako, 1:200, 4 °C). Antibody detection was performed using Alexa
Fluor® 568 goat anti mouse and AlexaFluor® 488 goat anti rabbit (Life
Technologies, 1:200, 30min). Cell nuclei were stained by DAPI (Sigma
Aldrich, 0.05 μg/ml, 10min). Finally, sections were mounted with
Fluoromount mounting medium (Sigma Aldrich).
Immunostained slides were photographed using a confocal Zeiss
LSM 780 microscope. Blood vessel density (number of vessels per mm2)
was determined by combining counting of α SMA positive structures
and morphological analysis. At least five randomly selected images of
the implanted area stained by a SMA fluorescent antibody were quan
tified for each animal.
2.6. Statistical Analyses
Statistical analyses were performed using GraphPad Prism 4 (Prism
GraphPad, San Diego, CA). Results are expressed as mean ± SEM.
Statistical comparisons between two unpaired groups were performed
using the t test (for data following a Gaussian distribution) or the Mann
Whitney test (for data not following a Gaussian distribution). For the
plasmatic CRP quantification, before after comparisons were performed
using the Wilcoxon matched pairs test. Comparisons between more
than two groups were performed using a one way ANOVA with Tukey's
post test or using a Kruskall Wallis test with the Dunnett's post test (in
case of a non Gaussian distribution). The influence of two factors was
determined using two way ANOVA with Bonferroni's post test. A value
of p < .05 was considered significant.
2.4.7. RNA Extraction and Real time Quantitative Reverse Transcription 
PCR (RT qPCR)
Total RNA was isolated from MCSs cultured in 2D or in 3D. Cell 
pellets or scaffolds were placed in Eppendorf tubes containing buffer 
RLT and 10% of β mercaptoethanol and then grinded using a mixer mill 
(Retsch) in the presence of 5 mm stainless steel bead. After that, total 
RNA extraction was performed using the RNeasy Mini Kit® (Quiagen) as 
specified by the manufacturer. RNA concentration was determined by 
measuring the absorbance at 260 nm in a NanoDrop® ND 1000 spec 
trophotometer.
RNA (300 ng per assay tube) was reverse transcribed to cDNA using 
the RT SuperScript II reverse transcriptase (Invitrogen). RT qPCR was 
performed on StepOne+ (Applied Biosystems) using SYBRR® Premix EX 
Taq™ (Tli RNaseH Plus), Rox Plus (TaKaRa Bio) for detection of rat 
FGF2 and rat GAPDH (glyceraldehyde 3 phosphate dehydrogenase). 
The reaction assay mix contained 3 ng of cDNA (1:10 diluted template 
cDNA), 0.2 μM of primers (Eurogentec) and the SYBR® Premix Ex Taq 
II, ROX Plus for a final volume of 10 μl per well. Quantification of the 
housekeeping rat cDNA GAPDH was used as an internal control.
The absence of contaminants was checked by RT qPCR assays of 
negative control samples in which the Superscript II was omitted. 
Melting curve analysis was performed to ensure purity of the PCR 
products. Relative quantification was determined using the compara 
tive CT method with data normalized to GAPDH. Experiments were 
performed in duplicate and results were treated with the StepOne 
Software v2.4 (Applied Biosystems). The sense and antisense primers 
used are:
3. Results
3.1. Alginate/Chitosan 3D PEC Scaffolds Physico chemical
Characterization
3.1.1. 3D PEC Scaffolds Porous Architecture
Three different PEC scaffold types with a constant alginate con
centration (1.5% w/w) and containing 60/40, 50/50 and 40/60 algi
nate/chitosan ratios (w/w) were prepared. In parallel, control scaffolds
composed of pure alginate (1.5% w/w, defined as 100/0 alginate/
chitosan ratio) or with pure chitosan (1.5% w/w, defined as 0/100
alginate/chitosan ratio) were prepared according to the same proce
dure.
Fig. 1 shows micro CT 2D slices reconstructions of alginate/chitosan
PEC scaffolds in comparison with alginate and chitosan ones, and
Table 1 summarizes porosity quantification data. All scaffolds were
found to present a homogeneous morphology characterized by a highly
interconnected macroporous structure. Morphometric analysis showed
that all PEC scaffolds presented 100% interconnected pores and a total
porosity equal or above 80%, significantly higher than 0/100 S (chit
osan scaffolds; total porosity of 63%). The reconstructed scaffolds' slices
reveal bigger pores and denser walls for PEC scaffolds in comparison
with reference ones. This can be attributed to alginate/chitosan PEC
presence, distributed within the scaffolds.
Concerning pore sizes, measurements on micro CT slices showed
average pore sizes between 170 and 201 μm for PEC scaffolds. They
exhibited larger pore sizes than reference scaffolds, with a significant
difference with chitosan reference 0/100 S. Pore density, spanning
from 17 to 10 pores per squared millimeter, significantly decreased
with raising the chitosan ratio within the PEC formulations (Table 1).
3.1.2. 3D PEC Scaffolds Swelling Behavior
With the goal to determine the time needed by the scaffolds to re
hydrate after MSC deposit, their swelling kinetics have been studied.
The obtained dried scaffolds readily absorbed culture medium and
swelled quickly. Their swelling kinetics, presented in Fig. 2, show that
within the first 5 min of rehydration the scaffolds have reached their
maximal swelling ratio, which remained stable afterwards. All scaffolds
preserved their morphology after rehydration and no scaffold de
gradation was observed within the 2 h of the experiment. However, PEC
scaffolds' swelling ratios were significantly lower and present less
variability than those measured for alginate and chitosan reference
scaffolds, probably due to the stable ionic interactions between chitosan
and alginate chains.
0/100-S100/0-S
40/60-S50/50-S60/40-S
A
B
Fig. 1. Micro-CT analysis of the scaffolds: 2D micro-CT images of their cross-section. A: reference alginate (100/0-S) and chitosan (0/100-S) scaffolds; B: PEC
scaffolds with various alginate/chitosan ratios 60/40 (60/40-S), 50/50 (50/50-S), and 40/60 (40/60-S). The scale bar is 1mm for both panels (A and B).
Table 1
Porosity quantification data on micro-CT reconstructions: mean pore diameter, mean pore density, porosity and voids interconnectivity of PEC and reference
scaffolds.
Alginate/chitosan 3D scaffold 100/0-S 60/40-S 50/50-S 40/60-S 0/100-S
Mean pore diameter (μm) 149 ± 4 170 ± 4 201 ± 5 194 ± 6 77 ± 1
Mean pore density (mm 2) 20.4 ± 0.4 16.5 ± 0.6 13.7 ± 0.1 10.2 ± 0.4 19.3 ± 0.4
Porosity (%) 83 80 82 82 63
Voids interconnectivity (%) 100 100 100 100 100
3.1.3. 3D PEC Scaffolds Viscoelastic Properties
Swollen scaffolds' rheological properties were studied in dynamic
conditions in their linear viscoelastic zone at a shear rate of 10 Pa
(Fig. 3). For all scaffolds the storage modulus (G′) was higher than the
loss modulus (G″) over a large frequency zone (between 10 and
0.01 Hz), which indicates the existence of viscoelastic gels with pre
dominant elastic behavior. In addition, the existence of a plateau for G′
and G″ in this frequency range reveals the formation of well structured
hydrogels. G′ values of PEC scaffolds increased proportionally to chit
osan ratio; they are typically 10 to 12 times higher than G′ of reference
alginate scaffold. For 50/50 S and 40/60 S, the values of storage
modulus at 0.5 Hz were even higher than values for reference chitosan
scaffold 0/100 S (50/50: 17058 Pa, 40/60: 24767 Pa, 0/100:
13833 Pa).
3.1.4. 3D PEC Scaffolds Mechanical (Tensile) Properties
Mechanical behaviors of the PEC and reference scaffold were eval
uated in swollen state using a uniaxial tensile test (Fig. 4). We observed
that for all scaffolds elongation is more or less linear until break and
that the linear region is longer when chitosan content is higher. In
addition, the higher the chitosan percentage, the neater the break. PEC
scaffolds presented increased Young's moduli compared to control al
ginate scaffold, as expected, due to the synergistic interactions between
the opposite charged polymers.
3.2. MSC Seeded Alginate/Chitosan 3D PEC Scaffolds: In Vitro Assays
3.2.1. MSC Viability, Retention and Proliferation Within Alginate/Chitosan
3D PEC Scaffolds
3D scaffolds were seeded with 100,000 MSCs and examined for cell
viability, retention, and proliferation.
Cell viability was evaluated by confocal imaging 1, 3, 7 and 15 days
post seeding using the Live/Dead® staining. Volume reconstructions of
sequential z plane images, starting from the scaffold surface, are pre
sented in Fig. 5. We observed that MSC viability was preserved during
the 15 days of in vitro culture, as jugged by the cells' bright green
fluorescent staining and the virtually absent red staining. Furthermore,
no significant difference was found in cell viability within the different
types of scaffolds during the whole in vitro culture period. On the
contrary, substantially higher cell densities were observed within PEC
scaffolds compared with control alginate scaffolds. Indeed, within PEC
scaffolds cell density was quite similar to that observed within chitosan
scaffold 0/100 S, which is known to favor cell adhesion. Moreover,
within PEC scaffolds cells presented a particular 3D distribution where
they formed clusters seeming strongly related to the formation and 3D
distribution of polyelectrolyte complexes (previously observed in
micro CT).
Seeding efficiency was measured by quantifying the total LDH ac
tivity of cell seeded scaffolds and of cells left at the bottom of the well
within 16 h of cell deposition. Our results show that the seeding effi
ciency was very high, above 90%, for all scaffold types (Fig. 6A). Within
PEC scaffolds the seeding procedure reproducibility was greater com
pared to control alginate and chitosan scaffolds.
Cell proliferation was measured over 2 weeks by quantifying the
amount of genomic DNA per scaffold (Fig. 6B). After one day of 3D
culture, MSC number within 40/60 S was maintained identical to the
number of cells used for seeding (95%), but not within control scaffolds
(minus 50% in 100/0 S and minus 30% in 0/100 S). At the end of the
two week period, cell number within 40/60 S was maintained similar
to the number of initially seeded cells. In contrast, within 100/ S and 0/
100 S cell number globally decreases all over the experience. At every
time point, cell number within 40/60 S was significantly superior to
that in 100/0 S and remained close and even higher to that within 0/
100 S. The cell loss between day 3 and day 7 within 40/60 S was fol
lowed by an increase in cell number by day 14 when it reached its
Fig. 2. Stability upon rehydration of the scaffolds: swelling ratios of reference
and PEC 3D scaffolds as a function of sample immersion time in cell culture
medium.
Fig. 3. Viscoelastic properties of reference and PEC 3D scaffolds in their fully swollen state: storage (G′) and loss (G″) moduli according to frequency sweeps in the
linear viscoelastic regime.
initial value at the moment of seeding. These results suggest that MSC
proliferate within 40/60 S, contrary to 100/0 S and 0/100 S.
SEM imaging at high magnification revealed the cellular mor
phology on the 40/60 S surface three days after seeding (Fig. 7). At this
time point the matrix is densely populated with fairly round shaped
cells, with a diameter of about 3 μm, presenting numerous fibrillar
extensions connecting them to the support (cell matrix interactions)
and to neighbouring cells (cell cell interactions). (Fig. 7A). A closer
view (Fig. 7B; zoomed area) shows that these cells adhered to the
matrix by mean of microvillus extensions of the cytoplasm forming
larger “feet” for adhesion to the scaffold. Cells were tightly caught with
a fiber network that we believe results from cell surface proteins' in
teractions with the 3D scaffold components. Cell cell interactions were
also noted via microvillus extensions between neighbouring MSCs.
Taken together, the in vitro experimental results indicate that PEC
formation endows new properties of 3D scaffolds which are beneficial
for MSC culture on the long term compared with alginate and chitosan
alone. Indeed, 40/60 S favors not only cell viability, but also cell ad
hesion and proliferation. Therefore, we selected this formulation for
further tests.
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Fig. 4. Mechanical behavior of the scaffolds in their fully swollen state using a uniaxial tensile test. A: stress versus strain curves of alginate reference scaffold (100/0-
S), chitosan reference scaffold (0/100-S) and a 50/50 PEC scaffold (50/50-S); B: Young's moduli in traction of the 3D scaffolds according to alginate/chitosan ratio. *:
p≤ .05, based on two-way Anova analysis.
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Fig. 5. Cell seeding of rat MSC cultured within reference and PEC 3D scaffolds. Confocal z-planes (from the surface: 1 to the bottom: 10) of MSC-seeded scaffolds
observed after a Live/Dead staining (live cells in green and dead cells in red) 1, 3, 7 and 15 days after seeding. The scale bar is 200 μm. Each photo refers to green and
red channels at each time point. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 6. A: MSC retention efficiency of the 30 scaffolds; B: MSC viability within 
30 scaffolds. • denotes a significant difference compared to rat MSC on a cul­
ture plate (*: p s .05, ••: p s .01, •••: p s .001, based on Anova analysis). 
Fig. 7. Scanning electron microscopy examination of MSC seeded within 40/60 
PEC scaffold (40/60-S) after 3 days of in vitro cu lture. A:. overview; B: zoom on 
an MSC. The scale bar is 10 µm for panel A and 1 µm for panel B. 
3.2.2. FGF2 MSC Secrelion Ability Within 40/60 PEC Scaffolds 
We investigated the FGF2 secretion in 3D culture conditions by 
quantification in the culture medium of MSC seeded within 40/60 PEC 
3D scaffolds. Analyses were performed 24 h after seeding and results 
were compared to the amount measured in 20. 
We performed Western blot analyses on whole cell lysates (Fig. 8A 
and B) and also checked the expression levels for FGF2 mRNAs by re 
verse transcription and quantitative PCR (Fig. 8C). We found that FGF2 
protein and FGF2 mRNA expressions were slightly higher within 40/60 
PEC scaffold (40/60 S) than in 2D culture conditions, thus clearly 
showing that 40/60 PEC scaffolds permit to maintain and even have a 
tendency to promote FGF2 MSC secretion ability. 
3.3. 40/60 PEC Scaffold In Vivo Biocompatibility and Vascularization 
Aftu Implantation 
As a proof of concept, we implanted the 40/60 PEC scaffold in a 
muscle pouch on the pectoral muscle of healthy rats to investigate its 
biocompatibility and angiogenic properties. Host tissue's reaction and 
graft's fate were monitored at 9 and 28 days after implantation. 
Ail surgical incisions healed without evidence of infection. No  sig 
nificant differences in white blood cells level were observed between 
the control group and the acellular scaffold group (data not shown). 
Inflammation secondary to scaffold grafting was evaluated through the 
quantification of plasmatic C reactive protein (CRP) and no significant 
differences were observed in concentrations between the experimental 
groups along the study (Table 2). As an example, CRP values were 
465 ± 12 µg/ml for the control group and 467 ± 68 µg/ml for the 
acellular scaffold group at day 9. These results show that the animais 
did not present systemic infection nor inflammation. 
In order to evaluate host's immune reaction, as well as scaffold's 
engraftment and vascularization, grafts were harvested post mortem 
and stained with hematoxylin eosin or immunostained for alpha SMA 
and VWF. 
Hematoxylin eosin stained sections on Fig. 9 reveal tissue response 
to scaffold implantation. The 40/60 PEC 3D scaffold appear well in 
tegrated within the muscular tissue 28 days post implantation (Fig. 8A). 
Grafts' biodegradation gradually progressed over time and the new 
tissue integrated well with adjacent muscles. At this time point a large 
number of small functional blood vessels (diameter 15 20 µm) con 
taining erythrocytes were present between the degrading biomaterial 
fragments. The fibrous capsule was reduced to a thin (about 15 µm 
thick) and vascularized interface between the biomaterial and the 
muscular tissue (arrows on Fig. 9B and C). These results demonstrate 
the resolution of the inflammatory process and excellent tissue en 
graftment of 40/60 S. 
In vivo vascularization of the implanted constructs was analyzed by 
staining for VWF and alpha SMA to detect endothelial cells and smooth 
muscle cells. Examination of immunostained sections revealed the 
presence of blood vessels throughout the granular tissue resulting from 
the implant's biodegradation. The number of SMA positive vessels/mm2 
was 166 ± 11.4. This result indicates that alginate chitosan PEC 40/60 
scaffolds support vascularization, a very important fact. 
4. Discussion 
One of the major challenges in the field of soft tissues cell therapy is 
to design strategies allowing the administration of stem/progenitor 
cells taking the maximum advantage of their therapeutic properties by 
increasing their survival and paracrine activities and decreasing their 
potential side effects. To that aim, the interest of a scaffold to improve 
the administration and optimize ce!! survival is now widely recognized. 
In this field, polymers of natural origin are widely used because of a 
variety of advantages, such as their good biocompatibility and biode 
gradability, and the similarity of their networks with the extracellular 
matrix. According to the previous reports, collagen, gelatin, alginate, 
chitosan, hyaluronic acid, agarose, and fibrin are the common biopo 
lymers applied (Asgharia et al., 2017; Newsom et al., 2019; Tiwari 
et al., 2019; Li et al., 2019; Kaiser and Coulombe, 2015; Perez Estenaga 
et al., 2018; Rane and Christman, 2011; Perez et al., 2017; Lev and 
Seliktar, 2018; Liu et al., 2019; Saberianpour et al., 2018). 
The main limitation of the scaffolds obtained from biopolymers is 
their Jack of sufficient mechanical properties for handling and im 
plantation, and their porosity, which is initially too low to allow ce! 
lular invasion. Different techniques can be used to strengthen biopo 
lymers' networks, including chemical modifications and crosslinking 
(Oryana et al., 2018). However, these solutions, if they lead to me 
chanically stronger structures, are often at the expense of biocompat 
ibility due to the use of solvents, and potentially toxic reaction 
intermediates or by products.
The use of two of more biopolymers, associated to form inter
penetrating networks, complexes, multilayers or fibers is a promising
alternative as it does not imply the use of potentially toxic chemicals
(Luan et al., 2017; Rahmani Del Bakhshayesh et al., 2018; Li et al.,
2018; Bombaldi de Souzaa et al., 2019). Among these possibilities the
formation of polyelectrolyte complexes (PEC), involving a negatively
charged polymer and a positively charged polymer is one of the most
attractive strategies in terms of gain in mechanical properties without
loss of biocompatibility. Chitosan is often used as the positively charged
polymer because of its biocompatibility (Periayah et al., 2016) and its
easily chemically modifiable structure, mainly to increase its solubility
(Tan and Marra, 2010). Concerning the positively charged polymers,
the potential choice is greater (Wu et al., 2017). Among possibilities,
alginates are frequently used because of their plant origin (unlike col
lagen) and their widely recognized biocompatibility (Sarker and
Boccaccini, 2017; Guarino et al., 2017; Bedian et al., 2017).
Different ways of associating alginate and chitosan have been de
scribed in the literature: by mixing at room (Florczyk et al., 2011; Xu
et al., 2019; Lv et al., 2019) or higher temperature (Fletcher et al.,
2017), bilayer (Banerjee and Ganguly, 2019) or layer by layer (Silva
et al., 2017) assemblies, crosslinking (Baysal et al., 2016; Naghizadeha
et al., 2018, Zhang et al., 2018), 3D printing (Liu et al., 2018), … They
lead to biocompatible buildings whose mechanical properties can be
variable (Francis et al., 2013; Salehi et al., 2019; Lv et al., 2019; Xu
et al., 2019), even up to correspond to the mechanical properties of
hard tissues (Li et al., 2005; Florczyk et al., 2013). In this context our
strategy was to let these biopolymers chemically unmodified, in order
to maintain their excellent initial biocompatibility, and to work on the
process to obtain a macroporous 3D architecture with improved rheo
logical properties compared with reference polymers. By playing on the
mixing conditions and the drying process, we have obtained a family of
scaffolds whose mechanical resistance can be adapted to that of soft
tissues. Without the use of chemical modifications, porogens or time
consuming or expensive processes, we have been able to obtain porous
structures that allow deep seeding. After encouraging first results in the
cardiac field, we here go further in the characterization of this family of
biomaterials and the evaluation their potential as scaffolds aimed to cell
therapy of soft tissues.
In the first part of this study we performed a thorough study of the
relationships between chemical structure, 3D morphology and me
chanical properties of scaffolds obtained by mixing alginate with chit
osan in different proportions. We aimed at clarifying the physico che
mical parameters which are likely to affect material cell interactions in
3D. We used micro CT to determine the impact of the preparation
method on the morphology of the obtained scaffolds. The micro CT
study showed that the PEC, formed as a result of alginate and chitosan
interactions, give way after freeze drying to a highly porous material
(Fig. 1) with interconnected pores whose diameters were in the range
reported to allow cell seeding and vessel ingrowth (Zeltinger et al.,
2001; Salem et al., 2002). Comparison of the micro CT slices of the
different types of scaffolds suggests that the differences in micro
architecture are due to the degree of complexation between the two
polymers and 3D distribution of the formed PEC in the bulk material.
These differences in chemical composition and in 3D structure im
pacted the mechanical properties of the scaffolds. Rheological study in
dynamic conditions (Fig. 3) highlighted the linear response to cyclic
and progressive stimuli. PEC scaffolds presented a visco elastic beha
vior with predominant elastic properties over a large frequency range
(0.01 to 5 Hz) which demonstrates the efficacy of the preparation
process to form highly structured polymeric network. The storage
modulus increased with chitosan proportion and for 50/50 S and 40/
60 S it achieved values greater than that of semi crystalline chitosan
gel. Thus, the dynamic analysis at different frequencies highlighted
their resistance to strain and elastic behavior. The mechanical test in
tension (Fig. 4) showed their capacity to support high level of de
formation (up to 50% for 50/50 S) without breaking and preserving a
relatively linear response to stress.
The obtained PEC scaffolds stiffness may vary according to alginate/
chitosan ratio. Soft tissues mechanical properties reported in the lit
erature have been determined by means of different mechanical testing
methods. Tissues elasticities measured by atomic force microscopy span
from 0.5 to 1.5 kPa for nerve and liver tissues (Flanagan et al., 2002;
Georges et al., 2007) to 5 9 and 8 17 for smooth and skeletal muscle
tissues (Engler et al., 2004; Berry et al., 2006; Collinsworth et al., 2002;
Engler et al., 2006). Few studies have used tensile tests to determine the
elastic modulus of biological tissues. Silver et al. have found that in a
tensile test the tendon's elastic modulus was 2 8 kPa (Silver, 2006);
Wagenseil et al. have found that the arterial wall presented an elastic
modulus of 0.3 to 1 kPa (Wagenseil and Mecham, 2009). The proposed
PEC 3D scaffolds, whose tensile elastic moduli are ranging from 0.5 to
1.5 kPa, present mechanical properties answering those of soft tissues.
Under other experimental conditions the increase in Young's mod
ulus obtained by associating alginate and chitosan reaches values
Fig. 8. FGF2 secretion ability of MSC cultured within 40/60 PEC scaffold or in culture plate 24 h post-seeding. A: quantification by Western blot of FGF-2 expression;
B: corresponding image from the Western blot; C: expression levels for FGF2 mRNAs by reverse transcription and quantitative PCR.
Table 2
Plasmatic C-reactive protein (CRP) quantification at D0, D9 and D28 post im-
plantation for control (sham) group and acellular PEC scaffold (40/60-S) group.
CRP (μg/ml) D0 D9 D28
Sham 456.3 ± 21.74 465.4 ± 12.51 505.2 ± 26.41
40/60-S 511.4 ± 22.76 467.2 ± 68.07 526.2 ± 49.55
Fig. 9. hnplantation of a 40/60 PEC scaffold in a muscle pouch on the pectoral muscle of healthy rats: Host tissue's reaction and graft's fate 28 days after im­
plantation. 
Optical micrographs of an implanted 40/60 PEC scaffold harvested 28 days after implantation: A: overview; B and C: zoom to the fibrous capsule formed around the 
implant. M: muscle; S: scaffold. Black arrows indicate newly-formed blood vessels containing erythrocytes. Scale bars correspond to 1 mm for panel A and to 100 µm 
for panels B and C. 
allowing their use for bone (Park et al., 2013; Florczyk et al., 2013; Li 
et al., 2005) or cartilage (Qi et al., 2011; Li et al., 2008; Shao and 
Hunter, 2007; Li and Zhang, 2005) tissue reconstruction. In these stu 
dies the Young's modulus is of the order of several MPa, which is about 
100 times higher than Young's modulus measured for our scaffolds 
described here. These notable differences can be explained by the 
polymer choice (molecular weight, chitosan's degree of acetylation, and 
alginate's M/G ratio), their respective concentrations in the mix, the 
final polymer concentration, the type and concentration of the gelling 
ions and the freezing regime during freeze drying. The variety of 
propa-ties which can be obtained underlines the importance of poly 
mers and technological process choice. 
In view of matrix assisted cell therapy, key parameters to analyze 
are cell viability, retention and proliferation. These parameters, re 
sulting from the cell material interactions, condition the numbers of 
functional cells present in the scaffold and determine the long term 
success of the therapy. We observed that upon rehydration, all scaffolds 
swelled quickly enough to allow efficient cell seeding thanks to their 
porosity and hydrophilic character (Fig. 2). Using confocal microscopy 
examination of double stained cells with calcein and ethidium homo 
dimer (Fig. 5), a strong prevalence of live cells on dead cells was ob 
served. Moreover, cells were distributed in depth as soon as one day 
after seeding. Overall, these results confirm that the scaffolds' porous 
structure, together with the used seeding method, allowed an efficient 
cell penetration through the thickness of the scaffold. All scaffolds were 
biocompatible and favored long term cell culture. 
Cell retention capacity was evaluated within 16 h of seeding and 
then cell number within scaffolds was followed during 14 days. Ali 
scaffolds presented an excellent seeding efficiency (-9()0/4) in the first 
hours after seeding (Fig. 6A). Such a high level of cell retention is un 
derstandable because the cells entrapped in the pores of the scaffold 
had little chance to escape. However, 24 h after seeding, MSC were 
efficiently retained only within 40/60 S. This sharp drop in cell num 
bers for 100/0 S and 0/100 S within the first day after seeding could be 
due to the fact that alginate and chitosan gels are rather fragile physical 
gels and may be damaged during centrifugation (used for seeding), 
which entails cell release out of scaffolds. 
Over the following days of in vitro culture (Fig. 6B), cell number 
remained close to the nurnber of seeded cells within 40/60 S not only 
thanks to efficient cell retention but also to cell proliferation, particu 
larly noticeable bet ween day 7 and day 14. In contrast, in the reference 
scaffolds 100/0 S and 0/100 S, cell number globally decreased. 
MSC interactions with 3D PEC scaffolds were examined in this study 
using SEM microscopy (Fig. 7). Our results revealed that MSC seeded 
within the 40/60 PEC scaffold established anchoring areas with the 
substrate through cytoplasmic extensions. Moreover, in a previous 
publication of our team we have shown by mean of actin vinculin 
staining and confocal microscopy that the alginate/chitosan ratio 40/ 
60 fostered cell adhesion, contrary to reference alginate (Ceccaldi et al., 
2014). Taken together, these observations demonstrate that the studied 
5. Conclusion
In this study we showed that alginate chitosan scaffolds are valuable
candidates permitting to promote MSC viability and ease of implanta
tion for soft tissue cell treatment. We developed a 3D porous scaffold
with suitable porous architecture and mechanical properties using
naturally derived biomaterials which, combined with MSC, could be
used for cell therapy of ischemic disorders. Our strategy is an attractive
way to take advantage of the MSC's paracrine effects and is original for
the soft tissue engineering field.
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scaffold has the potential to provide an appropriate microenvironment 
for 3D MSC culture and further ensures its biocompatibility.
In addition, we observed in confocal fluorescence microscopy that 
within PEC scaffolds MSC formed clusters. This cell distribution could 
be the consequence of the PEC scaffolds' inhomogeneous porosity, ob 
served in micro CT, in terms of pore size and wall thickness, compared 
to reference scaffolds. It could also be related to the 3D distribution of 
the opposite charge PECs generated by mixing alginate and chitosan 
which create zones favoring cell attachment. Although chitosan is 
known for its good cell adhesion properties (Ceccaldi et al., 2014), the 
lack of cell proliferation within 0/100 S could be due to its small pore 
diameter evidenced in microtomography. Another factor contributing 
to cell loss could be the progressive degradation of the alginate and 
chitosan hydrogels over the two week culture period.
Our in vitro experiments demonstrated the drastic beneficial effect 
of PEC formation on MSC ingrowth: the 40/60 S scaffold provided 
better MSC retention and favored their proliferation during a 2 week 
culture. FGF2 quantification in the medium of cell seeded scaffolds 
showed that this factor is efficiently secreted without major interaction 
with the biopolymers constituting the scaffold. Moreover, 40/60 PEC 
scaffolds have a tendency to promote FGF2 MSC secretion ability.
In the second part of this study, we assessed the biocompatibility of 
the PEC scaffold by intramuscular implantation on healthy rats. 
Biocompatibility of engineered scaffolds is a critical issue for the long 
term efficacy of this therapeutic approach. Although a consistent body 
of literature exists on alginate's and chitosan's biocompatibility upon 
implantation (Guarino et al., 2015), it was necessary to assess the 
biocompatibility of the scaffolds prepared in this study. Quantification 
of plasmatic CRP and hematology analyses demonstrated the lack of 
chronic inflammation secondary to implantation. During the one month 
follow up (Fig. 9), the scaffold degraded progressively without immune 
exacerbation. Neovascularization is another critical point which de 
termines the success of tissue engineering on the long term. As a con 
sequence, the numerous newly formed blood vessels we observed 
1 month after implantation is one more element demonstrating the 
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